At a University of Georgia study committee, pharmacologists, treatment providers and parents urged regulation and testing of kratom products, distinguishing dangerous concentrated extracts from natural leaf and urging product standards, age limits and stronger enforcement.

Manufacturers argued that licensed, tested dietary‑supplement extracts can be standardized and tracked, while many users and clinicians warned that concentrated synthetics and extracts (7‑hydroxy, pseudoindoxil) are driving poisonings and should be banned.